Table of Contents Author Guidelines Submit a Manuscript
Radiology Research and Practice
Volume 2012, Article ID 415616, 8 pages
http://dx.doi.org/10.1155/2012/415616
Research Article

Quantitative Assessment of 99mTc-Depreotide Uptake in Oesophageal Cancer and Precursor Conditions and Its Reflection in Immunohistochemically Detected Somatostatin Receptors

1Division of Medical Imaging and Technology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 141 86 Stockholm, Sweden
2Department of Radiology, Karolinska University Hospital Huddinge, 141 86 Huddinge, Stockholm, Sweden
3Gastrocentrum, Surgery, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden
4Division of Pathology, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden
5Division of Nuclear Medicine, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden

Received 8 July 2011; Revised 15 December 2011; Accepted 15 December 2011

Academic Editor: Weili Lin

Copyright © 2012 Gunnar Herlin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Reubi, J. Laissue, E. Krenning, and S. W. J. Lamberts, “Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications,” Journal of Steroid Biochemistry and Molecular Biology, vol. 43, no. 1–3, pp. 27–35, 1992. View at Google Scholar · View at Scopus
  2. D. J. Kwekkeboom and E. P. Krenning, “Somatostatin receptor imaging,” Seminars in Nuclear Medicine, vol. 32, no. 2, pp. 84–91, 2002. View at Google Scholar · View at Scopus
  3. I. Virgolini, M. Leimer, H. Handmaker et al., “Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, Tc99m-P829,” Cancer Research, vol. 58, no. 9, pp. 1850–1859, 1998. View at Google Scholar · View at Scopus
  4. T. Reisine and G. I. Bell, “Molecular biology of somatostatin receptors,” Endocrine Reviews, vol. 16, no. 4, pp. 427–442, 1995. View at Google Scholar · View at Scopus
  5. Y. C. Patel, “Somatostatin and its receptor family,” Frontiers in Neuroendocrinology, vol. 20, no. 3, pp. 157–198, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. D. Hoyer, G. I. Bell, M. Berelowitz et al., “Classification and nomenclature of somatostatin receptors,” Trends in Pharmacological Sciences, vol. 16, no. 3, pp. 86–88, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Ferran, Y. Ricart, M. Lopez et al., “Characterization of radiologically indeterminate lung lesions: Tc99m-depreotide SPECT versus 18F-FDG PET,” Nuclear Medicine Communications, vol. 27, no. 6, pp. 507–514, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Halley, A. Hugentobler, P. Icard et al., “Efficiency of 18F-FDG and Tc99m-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 9, pp. 1026–1032, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. T. Martins, J. Sena Lino, S. Ramos, and L. Oliveira, “Tc99m-depreotide scintigraphy in the evaluation of indeterminate pulmonary lesions: clinical experience,” Cancer Biotherapy and Radiopharmaceuticals, vol. 19, no. 2, pp. 253–259, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. R. Axelsson, G. Herlin, M. Bååth, P. Aspelin, and K. G. Kölbeck, “Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer,” Acta Radiologica, vol. 49, no. 3, pp. 295–302, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. G. Herlin, L. Ideström, L. Lundell, P. Aspelin, and R. Axelsson, “Feasibility of imaging esophageal cancer with labeled somatostatin analogue,” International Journal of Molecular Imaging, vol. 2011, Article ID 279345, 6 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  12. P. E. Shrout and J. L. Fleiss, “Intraclass correlations: uses in assessing rater reliability,” Psychological Bulletin, vol. 86, no. 2, pp. 420–428, 1979. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Herlin, K. G. Klbeck, P. L. Menzel et al., “Quantitative assessment of Tc99m-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations,” Acta Radiologica, vol. 50, no. 8, pp. 903–908, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. D. J. Kwekkeboom, G. S. Kho, S. W. J. Lamberts, J. C. Reubi, J. A. Laissue, and E. P. Krenning, “The value of octreotide scintigraphy in patients with lung cancer,” European Journal of Nuclear Medicine, vol. 21, no. 10, pp. 1106–1113, 1994. View at Google Scholar · View at Scopus
  15. J. Machac, B. Krynyckyi, and C. Kim, “Peptide and antibody imaging in lung cancer,” Seminars in Nuclear Medicine, vol. 32, no. 4, pp. 276–292, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus